Der implantierbare Event-Rekorder bei Synkopen unklarer Genese und als Langzeit-Monitoring nach Vorhofflimmerablation

Abstract

Gold standard for clarification of the cause of arrhythmogenic syncope is the symptom-rhythm-correlation. This could only be achieved by continuous long term monitoring with an implantable loop recorder. It appears that the implantable loop recorder might become the reference standard to be adopted when an arrhythmic cause of syncope is suspected but not sufficiently proved to allow an aetiological treatment.

Continuous long term monitoring plays a key role in assessing the efficacy of rhythm control strategies especially in atrial fibrillation. The precise determination of freedom from atrial fibrillation is a crucial outcome parameter and a prerequisite for establishing new therapeutic strategies. Furthermore it could support the physician to guide antithrombotic treatment in atrial fibrillation patients after rhythm control therapy.

Literatur

• 1 Kinlay S, Leitch J W, Neil A. et al . Cardiac event recorders yield more diagnoses and are most cost-effective than 48-hour holter monitoring in patients with palpitations. A controlled clinical trial.  Ann Intern Med. 1996;  124 16-20
• 2 Schuchert A, Maas R, Kretzschmar C. et al . Diagnostic yield of external loop recorders in patients with recurrent syncope and negative tilt table test.  Pacing Clin Electrophysiol. 2003;  26 1837-1840
• 3 Linzer M, Pritchett E L, Pontinen M. et al . Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope.  Am J Cardiol. 1990;  66 214-219
• 4 Krahn A D, Klein G J, Yee R. et al . Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators.  Circulation. 1999;  26 406-410
• 5 Moya A, Brignole M, Sutton R. et al . Reproducibility of electrocardiographic findings in patients with neurally-mediated syncope.  Am J Cardiol. 2008;  102 1518-1523
• 6 Seidl K, Rameken M, Breunung S. et al . on the behalf of the Reveal-Investigators. Diagnostic assessment of recurrent unexplained syncope with a new subcutaneously implantable loop recorder.  Europace. 2000;  2 256-262
• 7 Moya A, Sutton R, Ammirati F. et al . Guidelines for the diagnosis and management of syncope (version 2009). The task force for the diagnosis and management of syncope of the european society of cardiology (ESC).  Eur Heart J. 2009;  30 (21) 2631-2671
• 8 Lempert T, Bauer M, Schmidt D. Syncope: a vidometric analysis of 56 episodes of transient cerebral hypoxia.  Ann Neurol. 1994;  36 233-237
• 9 Brignole M, Alboni P, Benditt D. et al., (Task Force on Syncope) . Guidelines on management (diagnosis and treatment) of syncope.  Eur Heart J. 2001;  22 1256-1306
• 10 Middlekauff H, Stevenson W, Stevenson L, Saxon L. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope.  J Am Coll Cardiol. 1993;  21 110-116
• 11 Brignole M, Vardas P, Hoffman E. et al . Indications for the use of diagnostic implantable and external ECG loop recorders.  Europace. 2009;  11 671-687
• 12 Sheldon R, Rose S. Components of clinical trials for vasovagal syncope.  Europace. 2001;  3 233-240
• 13 Solano A, Menozzi C, Maggi R. et al . Incidence, diagnostic yield and safety of the implantable loop-recorder to detect the mechanism of syncope in patients with and without structural heart disease.  Eur Heart J. 2004;  25 1116-1119
• 14 Krahn A, Klein G J, Yee R, Skanes A C. Randomized Assessment of Syncope Trial. Conventional diagnostic testing versus a prolonged monitoring strategy.  Circulation. 2001;  104 46-51
• 15 Brignole M, Moya A, Menozzi C. et al . Proposed electrocardiographic classification of spontaneous syncope documented by an implantable loop recorder.  Europace. 2005;  7 14-18
• 16 Mewis C, Neuberger H R, Böhm M. Vorhofflimmern.  DMW. 2006;  131 2843-2853
• 17 Gage B F, Watermann A D, Shannon W. et al . Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation.  JAMA. 2001;  285 2864-2870
• 18 Kottkamp H, Tanner H, Kobza R. et al . Time course and quantitive analysis of atrial fibrillation episode number and duration after circular plus linear left atrial ablation: trigger elimination or substrate modification, early or delayed cure?.  J AM Coll Cardiol. 2004;  44 869-877
• 19 Kirchhof P, Auricchio A, Bax J. et al . Outcome parameters for trials in atrial fibrillation. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association.  Europace. 2007;  9 1006-1023
• 20 Calkins H, Brugada J, Packer D L. et al . HRS/EHRA/ECAS expert consensus statement on catheter and surgical of atrial fibrillation:recommendations for personnel, policy, procedures and follow-up.  Europace. 2007;  9 335-379
• 21 Chart international consensus document on atrial fibrillation ablation.  J Cardiovasc Electrophysiol. 2007;  18 560-580
• 22 Ziegler P D, Koehler J L, Mehra R. Comparison of continuous versus intermittent monitoring of atrial arrhythmias.  Heart Rhythm. 2006;  3 1445-1452
• 23 Hoefman E, van Weert H, Boer K R. et al . Optimal duration of event recording for diagnosis of arrhythmias in Patients with palpitations and light-headedness in the general practice.  Family Practice. 2007;  24 11-13
• 24 Vasamreddy C R, Dalal D, Dong J. et al . Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation. J.  Cardiovasc Electrophysiol. 2006;  17 134-139
• 25 Martinek M, Aichinger J, Nesser H J. et al . New insights into long-term follow-up of atrial fibrillation ablation: full disclosure by an implantable pacemaker device.  J Cardiovasc Electrophysiol. 2007;  18 818-823
• 26 Hoffmann E, Sulke N, Edvardsson N. et al . New insights into the initiation of atrial fibrillation: a detailed intraindividual and interinduvidual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features.  Circulation. 2006;  113 1933-1941
• 27 Botton G L, Padeletti L, Santini M. et al . Presence and duration of atrial fibrillation detected by continous monitoring: crucial implications for risk of thromboembolic events.  J Cardiovasc Electrophysiol. 2009;  20 241-248
• 28 Hanke T, Charitos E I, Stierle U. et al . Twenty-four hour holter monitor follow-up does not provide accurate heart rhythm stauts after surgical atrial fibrillation ablation therapy: up to 12 months experience with a novel permanently implantable heart rhythm monitor device.  Circulation. 2009;  120 (Suppl 1) S177-S184
• 29 Jaboudon D, SztajzelJ , Sievert K. et al . Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack.  Stroke. 2004;  35 1647-1651